Published in Hepatology on December 01, 2004
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial. J Infect Dis (2003) 1.25
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial. Antivir Ther (2005) 1.18
A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients: SPARTAN study results. HIV Clin Trials (2012) 1.13
Neutrophil extracellular traps in sepsis. Shock (2014) 1.04
HIV seroincidence estimates among at-risk populations in Buenos Aires and Montevideo: use of the serologic testing algorithm for recent HIV seroconversion. J Acquir Immune Defic Syndr (2006) 0.98
False positive reactions in confirmatory tests for syphilis in presence of antiphospholipid antibodies: misdiagnosis with prognostic and social consequences. Dermatol Online J (2006) 0.86
Correlations between synthetic peptide-based enzyme immunoassays and immunofluorescence assay for detection of human herpesvirus 8 antibodies in different Argentine populations. J Med Virol (2006) 0.86
HLA-driven convergence of HIV-1 viral subtypes B and F toward the adaptation to immune responses in human populations. PLoS One (2008) 0.85
Thrombophilia in human immunodeficiency virus-infected patients with osteonecrosis: Is there a real connection? The first case-control study. Clin Appl Thromb Hemost (2007) 0.82
Role of 4G/5G promoter polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1) gene in outcome of sepsis. Thromb Res (2009) 0.81
Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs. J Gastroenterol Hepatol (2013) 0.80
Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients. J Med Virol (2007) 0.80
4G/5G plasminogen activator inhibitor-1 and -308 A/G tumor necrosis factor-α promoter gene polymorphisms in Argentinean lupus patients: focus on lupus nephritis. Clin Exp Med (2012) 0.79
High rates of serum selenium deficiency among HIV- and HCV-infected and uninfected drug users in Buenos Aires, Argentina. Public Health Nutr (2011) 0.79
Circulating Epstein-Barr virus (EBV) in HIV-infected patients and its relation with primary brain lymphoma. Int J Infect Dis (2006) 0.79
The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene is associated with the risk of developing systemic lupus erythematosus in Argentinean patients: a multicenter study. Eur Cytokine Netw (2012) 0.77
[Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?]. Acta Gastroenterol Latinoam (2009) 0.77
Detection of HIV-1 dual infections in highly exposed treated patients. Virol J (2011) 0.77
[Nocardiosis in patients with human immunodeficiency virus infection]. Enferm Infecc Microbiol Clin (2005) 0.76
[Plasma homocysteine in human immunodeficiency virus infected patient]. Medicina (B Aires) (2003) 0.76
[Neutrophil extracellular traps: a 2-faced host defense mechanism]. Med Clin (Barc) (2012) 0.75
In vitro replication competence of a hepatitis B genotype D/A recombinant virus: dissimilar biological behaviour regarding its parental genotypes. J Gen Virol (2013) 0.75
[Effect of age on CD4+ cells regeneration in patients with hiv infection undergoing triple antiretroviral therapy]. Medicina (B Aires) (2002) 0.75
Role of -675 4G/5G in the plasminogen activator inhibitor-1 gene and -308G/A tumor necrosis factor-α gene polymorphisms in obese Argentinean patients. Genet Test Mol Biomarkers (2011) 0.75
Genital manifestations in women with AIDS. J Int Assoc Physicians AIDS Care (Chic) (2005) 0.75
Pharmacokinetics of indinavir/ritonavir (800/100 mg twice a day) combined with efavirenz in HIV-infected patients. AIDS (2004) 0.75